CATALOGO DEI PRODOTTI DELLA RICERCA

CIPRIANI, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.666
EU - Europa 9.076
AS - Asia 6.564
SA - Sud America 1.121
AF - Africa 158
Continente sconosciuto - Info sul continente non disponibili 141
OC - Oceania 27
Totale 28.753
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.462
SG - Singapore 2.811
RU - Federazione Russa 2.747
GB - Regno Unito 2.391
CN - Cina 1.724
IT - Italia 1.224
BR - Brasile 883
VN - Vietnam 624
FR - Francia 599
HK - Hong Kong 587
FI - Finlandia 482
DE - Germania 481
IE - Irlanda 387
SE - Svezia 347
KR - Corea 220
UA - Ucraina 160
BD - Bangladesh 122
CA - Canada 103
AR - Argentina 86
IN - India 73
NL - Olanda 63
TR - Turchia 61
ID - Indonesia 56
NG - Nigeria 52
MX - Messico 47
JP - Giappone 46
EC - Ecuador 34
IQ - Iraq 34
PK - Pakistan 33
AT - Austria 29
ZA - Sudafrica 28
CO - Colombia 27
ES - Italia 27
AU - Australia 24
PL - Polonia 24
IL - Israele 23
PH - Filippine 22
PY - Paraguay 20
BE - Belgio 19
RO - Romania 19
SA - Arabia Saudita 18
UY - Uruguay 18
VE - Venezuela 17
CL - Cile 15
PE - Perù 14
KE - Kenya 13
MA - Marocco 13
AZ - Azerbaigian 12
CR - Costa Rica 12
JO - Giordania 12
CH - Svizzera 11
EG - Egitto 11
DZ - Algeria 9
EU - Europa 9
UZ - Uzbekistan 9
AE - Emirati Arabi Uniti 8
GR - Grecia 8
HU - Ungheria 8
JM - Giamaica 8
TN - Tunisia 8
BG - Bulgaria 7
BY - Bielorussia 7
KZ - Kazakistan 7
NP - Nepal 7
GT - Guatemala 6
HN - Honduras 6
LT - Lituania 6
MY - Malesia 6
IR - Iran 5
PT - Portogallo 5
TH - Thailandia 5
AL - Albania 4
AM - Armenia 4
BO - Bolivia 4
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
KG - Kirghizistan 4
NI - Nicaragua 4
OM - Oman 4
QA - Qatar 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
AO - Angola 3
BB - Barbados 3
BN - Brunei Darussalam 3
LB - Libano 3
RS - Serbia 3
SI - Slovenia 3
TT - Trinidad e Tobago 3
UG - Uganda 3
EE - Estonia 2
GE - Georgia 2
KH - Cambogia 2
KW - Kuwait 2
LU - Lussemburgo 2
MN - Mongolia 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SC - Seychelles 2
Totale 28.591
Salva come PNG Salva come JPEG
Città #
Southend 2.103
Singapore 1.479
Jacksonville 1.302
Woodbridge 967
Ashburn 918
San Jose 850
Chandler 841
Moscow 738
Dallas 693
Ann Arbor 580
Hong Kong 578
Houston 563
Council Bluffs 434
Dublin 387
Verona 375
The Dalles 332
Beijing 291
Wilmington 226
Lawrence 219
Princeton 216
Ho Chi Minh City 202
New York 193
Los Angeles 151
Hanoi 128
Nanjing 128
Milan 118
Jinan 112
Buffalo 110
Shenyang 104
Santa Clara 90
São Paulo 79
Hebei 73
Rome 63
Redondo Beach 61
Helsinki 58
Munich 58
Dong Ket 56
Tianjin 53
Changsha 49
Abuja 48
Sindelfingen 47
Nanchang 45
Boardman 42
Haikou 40
Guangzhou 38
Hangzhou 38
Columbus 37
Orem 37
London 36
Ningbo 36
Washington 36
San Francisco 35
Tokyo 34
Chicago 32
Toronto 32
Dearborn 31
Norwalk 31
Redwood City 30
Zhengzhou 30
Taiyuan 29
Bologna 28
Frankfurt am Main 28
Naples 27
Atlanta 26
Jiaxing 26
Taizhou 25
Manchester 24
Turku 24
Mexico City 23
Phoenix 23
Shanghai 23
Lancaster 22
Brooklyn 21
Haiphong 21
Belo Horizonte 20
Florence 20
Brasília 19
Da Nang 19
Rio de Janeiro 19
Stockholm 19
Amsterdam 18
Montreal 18
Jakarta 17
Chennai 16
Montevideo 16
Barnet 15
Brussels 15
Fuzhou 15
Vienna 15
Warsaw 15
Denver 14
Guayaquil 14
Nuremberg 14
Düsseldorf 13
Falls Church 13
Johannesburg 13
Porto Alegre 13
Seattle 13
Campinas 12
Curitiba 12
Totale 17.490
Salva come PNG Salva come JPEG
Nome #
Efficacia del litio nella depressione resistente con rischio suicidario. Studio indipendente, pragmatico, multicentrico, di superiorità 656
Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials 446
Selective serotonin reuptake inhibitors and risk of suicide: A systematic review of observational studies 435
Efficacia del litio nella depressione resistente con rischio suicidario. Studio indipendente, pragmatico, multicentrico, di superiorità 424
[(123)I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism. 313
[Randomized trials, systematic reviews, meta-analyses: basic criteria in the world of scientific evidence]. 251
Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial 245
Antidepressants and benzodiazepines for panic disorder in adults 226
Development of a registry for monitoring psychotropic drug prescriptions: Aims, methods and implications for ordinary practice and research 204
An approach for modelling multiple correlated outcomes in a network of interventions using odds ratios 201
Assessing risk of bias in randomized controlled trials 199
Agomelatine efficacy and acceptability revisited: systematic review and meta-analysis of published and unpublished randomised trials 199
Azapirones versus placebo for panic disorder in adults 195
Allocation concealment and blinding in clinical trials 192
Adding aripiprazole improves major depressive disorder following incomplete response to antidepressants alone 192
"Wish bias" in antidepressant drug trials? 189
Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: results and lessons of an underpowered randomised clinical trial 187
Antidepressant drug prescription and risk of abnormal bleeding. A case-control study 186
Rationale and design of an independent randomised controlled trial evaluating the effectiveness of aripiprazole or haloperidol in combination with clozapine for treatment-resistant schizophrenia 186
Trasformare la pratica clinica in ricerca. Un invito a partecipare allo studio CHAT 184
Antidepressive Monotherapie 183
Are all antidepressants really the same? The case of fluoxetine: a systematic review 183
Sertraline versus other antidepressive agents for depression 183
Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia: a 12-month, randomized, naturalistic trial 183
Commentary: Haloperidol, risperidone and olanzapine are similarly effective for first-episode non-affective psychosis but have differing side effects 178
Imputing missing standard deviations in meta-analyses can provide accurate results 176
Trazodone nell'anziano con problemi di insonnia: quale il razionale? 174
Effect of antipsychotic drugs on cerebrovascular morbidity and mortality: a systematic review 173
Agomelatine and the brave old world of narrative-based medicine 172
Benzodiazepines and risk of dementia: true association or reverse causation? 172
What is a run-in phase? 169
Efficacy of selective serotonin reuptake inhibitors and adverse events: meta-regression and mediation analysis of placebo-controlled trials 168
Profilo di efficacia e tollerabilità dell'escitalopram rispetto agli altri farmaci antidepressivi nel trattamento acuto della depressione maggiore: revisione sistematice e meta-analisi. [Efficacy and tolerability profile of escitalopram versus other antidepressants in the acute treatment of major depressive disorder: A systematic review and meta-analysis] 167
Citalopram versus other anti-depressive agents for depression. 167
A fully Bayesian application of the Copas selection model for publication bias extended to network meta-analysis 166
A primer on network meta-analysis with emphasis on mental health 166
Implementation of treatment guidelines for specialist mental health care 166
Comparison of systematic and narrative reviews: the example of the atypical antipsychotics 165
Adherence therapy does not improve quality of life in people with schizophrenia [Comment] 165
Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis 164
Commentary: Antipsychotic plus mood stabiliser co-therapy is more effective than mood stabiliser mono-therapy at reducing acute bipolar mania 163
Antipsychotic drugs and cerebrovascular events in elderly patients with dementia: a systematic review 163
Antidepressants for Bipolar Disorder 162
Allowing for uncertainty due to missing continuous outcome data in pairwise and network meta-analysis 162
Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: a protocol for a randomised, independent, pragmatic, multicentre, parallel-group, superiority clinical trial 161
Understanding antipsychotic non-classical prescriptions: a quantitative and qualitative approach 160
Citalopram versus other anti-depressive agents for depression 159
A systematic review of calcium channel antagonists in bipolar disorder and some considerations for their future development 159
Citalopram versus other anti-depressive agents for depression 157
Efficacy of pharmacotherapy against core traits of borderline personality disorder: Meta-analysis of randomized controlled trials 156
Antidepressants and suicide symptoms: compelling new insights from the FDA's analysis of individual patient level data 156
Randomized trials published in Chinese or Western journals: comparative empirical analysis 155
Duloxetine versus other anti-depressive agents for depression 153
Associazione tra TCA e SSRI nella depressione resistente 152
Trasformare la pratica clinica in ricerca. Un invito a partecipareallo studio CHAT. 152
What is a systematic review? 149
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis 149
Beneficial and adverse effects of antidepressants on suicide mortality in individuals with major depression 148
Levels of evidence: can quality of systematic reviews be quantified? 147
Implementation of treatment guidelines for specialist mental health care 147
Seven criteria for improving effectiveness trials in psychiatry 146
Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis 146
Advancing evidence-based practice to improve patient care 145
Sertraline versus other antidepressive agents for depression 144
Antidepressants in unipolar major depression: what we need to know 144
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis 144
Conventional vs. atypical antipsychotic medications [Letter] 142
Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology 142
Use of antipsychotic drugs and mood stabilizers in women of childbearing age with schizophrenia and bipolar disorder: epidemiological survey. 141
Outcome reporting bias in clinical trials 140
Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis 140
What is a risk ratio? 139
Persistence with pharmacological treatment in the specialist mental healthcare of patients with severe mental disorders 139
Implementation of treatment guidelines for specialist mental health care 139
Does the addiction of a second antipsychotic drug improve clozapine treatment? 138
Paroxetine versus other anti-depressive agents for depression 137
What is a forest plot? 136
Benzodiazepine use in the real world of psychiatric practice: low-dose, long-term drug taking and low rates of treatment discontinuation 136
Depressive disorders 135
Escitalopram versus other antidepressive agents for depression 135
Psychological therapies versus pharmacotherapy for obsessive compulsive disorder (Protocol) 135
Fluoxetine versus other types of pharmacotherapy for depression (Review) 134
What is a Cochrane review? 134
Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: A 2-year follow-up multicenter study. 132
Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis 131
Comparative efficacy and acceptability of antimanic drugsin acute mania: a multiple-treatments meta-analysis 130
International dose differences in fluoxetine clinical trials conducted in patients with depression 129
Superiority, equivalence or non-inferiority? 129
Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysis 128
Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: A systematic review of randomized trials 127
Haloperidol alone or in combination for acute mania 127
Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia 127
Dalle revisioni narrative a quelle sitematiche e alle metanalisi, per un approccio moderno alla valutazione dei trattamenti farmacologici in psichiatria 126
Impact of regulatory changes on first- and second-generation antipsychotic drug consumption and expenditure in Italy 125
Conceptual and technical challenges in network meta-analysis 125
Efficacy and tolerability of milnacipran in the treatment of major depression in comparison with other antidepressants : a systematic review and meta-analysis 124
Does randomised evidence support sertraline as first-line antidepressant for adults with acute major depression? A systematic review and meta-analysis 124
What is a clinical trial protocol? 123
Hydroxyzine for generalised anxiety disorder. 123
Olanzapine in long-term treatment for bipolar disorder. 122
Totale 17.223
Salva come PNG Salva come JPEG
Categoria #
all - tutte 98.137
article - articoli 92.244
book - libri 406
conference - conferenze 0
curatela - curatele 0
other - altro 2.451
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.036
Totale 196.274
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022900 0 0 25 57 42 29 12 91 60 31 140 413
2022/20232.732 253 166 332 431 290 572 33 183 320 30 70 52
2023/20241.351 71 129 111 118 162 187 47 92 19 83 190 142
2024/20253.814 285 251 171 554 177 137 216 178 566 280 225 774
2025/202610.034 768 624 838 1.487 2.201 645 964 604 827 455 247 374
2026/20271.507 555 540 412 0 0 0 0 0 0 0 0 0
Totale 28.753